FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/086886 [Registered on: 14/05/2025] Trial Registered Prospectively
Last Modified On: 13/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A clinical study to evaluate efficacy of an ayurvedic formulation in the treatment of joint disease. 
Scientific Title of Study   Experimental and Clinical evaluation of Antiarthritic activity of an Ayurvedic formulation for the treatment of Sandhigata vata w.s.r.to Osteoarthritis. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Suresh Kumar Jaiswara 
Designation  Reader, Department of Dravyaguna Vijnana 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 294/3/1 A.P.C Road, Kolkata Department of Dravyaguna Vijnana , room no t11

Kolkata
WEST BENGAL
700009
India 
Phone  9681098261  
Fax    
Email  dr.sureshkjaiswara@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Suresh Kumar Jaiswara 
Designation  Reader, Department of Dravyaguna Vijnana 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 294/3/1 A.P.C Road, Kolkata, Department of Dravyaguna Vijnana,Room no t11

Kolkata
WEST BENGAL
700009
India 
Phone  9681098261  
Fax    
Email  dr.sureshkjaiswara@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jayanti Biswas 
Designation  M.D. Scholar Dept. of Dravyaguna Vijnana IPGAE&R at S.V.S.P 
Affiliation  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 
Address  Dept. of Dravyaguna Vijnana Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital 294/3/1 A.P.C Road, Kolkata, Depatment of Dravyaguna Vijnana, Room no t11

Kolkata
WEST BENGAL
700009
India 
Phone  9153694870  
Fax    
Email  jayanti.jbroy@gmail.com  
 
Source of Monetary or Material Support  
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital , 294/3/1 ,A.P.C. Road, Kolkata, West Bengal-700009 , India 
 
Primary Sponsor  
Name  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospita, Govt. of West Bengal 
Address  294/3/1 A.P.C Road, Kolkata-700009 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jayanti Biswas  Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital  294/3/1 A.P.C Road, Kolkata-700009,Depatment of Dravyaguna Vijnana , Room no t11
Kolkata
WEST BENGAL 
9153694870

jayanti.jbroy@gmai.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee for Clinical Trial on Human Subject, IPGAER, Kolkata   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M179||Osteoarthritis of knee, unspecified. Ayurveda Condition: SANDHIGATAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Gokshura and Sunthi, Reference: NA, Route: Oral, Dosage Form: Kwatha/Kashaya, Dose: 30(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 56 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patient having age between 40-70 years.
2,Patients of both sexes, irrespective of religion, habitat, income status, occupation etc.
3.Patients having symptoms of pain and swelling in the knee joints.
4.Kellgren Lawrence (Radiological scale) of e 2.
5.Patients with primary osteoarthritis-knee joints (single or both knees).
6.Patient willing to include themselves in the study through informed consent form. 
 
ExclusionCriteria 
Details  1.Patients having age bellow 40 and above 70 years.
2.patients suffering with disease like cardiac problem, diabetes mellitus, hepatic disorder, renal disease, malignancies, pregnant mother etc.
3.patients who are currently participating in any other clinical trails.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The primary outcome will be measured based on clinical outcome measures, Radiological outcome measures, Bio-chemical outcome measures, safety and tolerability outcome measures to determine the effectiveness and safety of the test drug for the treatment of Sandhigatavata (Osteoarthritis).   56 days (8 weeks) 
 
Secondary Outcome  
Outcome  TimePoints 
In the secondary outcome the effects of the test drug changing in the quality life to be assessed after completion of the treatment.  56 days (8 weeks)  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   09/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [dr.sureshkjaiswara@gmail.com].

  6. For how long will this data be available start date provided 06-01-2026 and end date provided 06-01-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   This clinical study which will take place at OPD and IPD of the IPGAE&R at SVSP Hospital, a single arm open label interventional clinical study of a Ayurvedic formulation for the treatment of Sandhigatavata (Osteoarthritis) on 60 patients for 56 days. The primary outcome will be measured based on clinical outcome measures, radiological outcome measures, bio-chemical outcome measures, safety and tolerability measures to determine the effectiveness and safety of the test drug for the treatment of Sandhigatavata (Osteoarthritis). The secondary outcome is the effects of the test drug in changing of quality of life to be assessed after completion of the treatment. 
Close